Direct Application of Integra Bilayer Matrices on Bare Calvarium Without Preliminary Burring

NCT05311124 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-10-18

No results posted yet for this study

Summary

This study is to determine if large, full thickness scalp wounds with exposed calvarium resulting from acutely created extirpative defects can be reliably and durably resurfaced with IDRT without burring or fenestration as a preliminary step, regardless of the size of the calvarial defect.

Conditions

  • Wound Care
  • Pressure Ulcer
  • Venous Ulcer
  • Surgical Wound
  • Trauma Wounds
  • Draining Wound

Interventions

DEVICE

Integra Dermal Regeneration template (IDRT)

Integra Dermal Regeneration Template is a two-layer skin regeneration system. The outer layer is made of a thin silicone film that acts as your skin's epidermis. It protects the wound from infection and controls both heat and moisture loss. The inner layer is constructed of a complex matrix of cross-linked fibers. This porous material acts as a scaffold for regenerating dermal skin cells, which enables the re-growth of a functional dermal layer of skin. Once dermal skin has regenerated, the silicone outer layer is removed and replaced with a thin epidermal skin graft.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    collaborator INDUSTRY
  • Joshua Choo

    lead OTHER

Principal Investigators

  • Joshua H Choo, MD · University of Louisville School of Medicine Division of Plastic Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-06-01
Completion
2023-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05311124 on ClinicalTrials.gov